Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population

scientific article published in April 2006

Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBMT.2005.11.518
P698PubMed publication ID16545726
P5875ResearchGate publication ID7232621

P2093author name stringHans A Messner
Jeffrey H Lipton
Gregory R Pond
P433issue4
P304page(s)422-429
P577publication date2006-04-01
P1433published inBiology of Blood and Marrow TransplantationQ15754328
P1476titleLong-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population
P478volume12

Reverse relations

cites work (P2860)
Q34349297A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics
Q90581648Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood
Q38922475BSHI Guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation
Q45783720CLL/SLL diagnosed in an adolescent
Q90124938Conditional Long-Term Survival after Autologous Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma
Q38405625Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD.
Q44889315Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT.
Q33710708Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation
Q35023409Long-term survival and late deaths after allogeneic hematopoietic cell transplantation
Q92462729Menstrual Blood Stem Cell Transplantation in Mice Model of Acute Liver Failure: Does Gender of Recipient Affect the Outcome?
Q41525058Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Q35665096Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation
Q53110668Prognosis of grade 3-4 acute GVHD continues to be dismal.
Q38628809Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.

Search more.